OrbiMed Advisors »

Belite Bio shares owned by OrbiMed Advisors

Quarter-by-quarter ownership of Belite Bio (BLTE) shares owned by OrbiMed Advisors from 13F filings

Historical chart of OrbiMed Advisors investment in Belite Bio

Tip: Access up to 7 years of quarterly data

All positions including Belite Bio held by OrbiMed Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Belite Bio by OrbiMed Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $2.0M 13k 153.99

More positions owned by OrbiMed Advisors

Edgewise Therapeutics (EWTX)
Enliven Therapeutics (ELVN)
Eli Lilly & Co. (LLY)
Mbx Biosciences (MBX)
Sinovac Biotech SHS
Astrazeneca Ord (AZN)
Structure Therapeutics Sponsored Ads (GPCR)
Sionna Therapeutics (SION)
Corvus Pharmaceuticals (CRVS)
Arrivent Biopharma (AVBP)
Abivax Sa Sponsored Ads Call Option (ABVX)
Guardant Health (GH)
Argenx Se Sponsored Adr (ARGX)
Merck & Co (MRK)
Uniqure Nv SHS (QURE)

View all positions for OrbiMed Advisors

Top funds holding Belite Bio

Darwin Global Management
Paradigm Biocapital Advisors
Rtw Investments
Millennium Management
Maverick Capital
Eventide Asset Management
Deerfield Management Company
T. Rowe Price Associates
Holocene Advisors
Logos Global Management
UBS Group
Morgan Stanley
Citadel Advisors
Goldman Sachs Group
Affinity Asset Advisors

View all funds holding Belite Bio